Media contacts

Iryna Mazur
+41 79 429 3671
+41 22 909 2920
imazur@gavi.org

Iryna Mazur

 

James Fulker
+41 79 429 5505
jfulker@gavi.org
 

James Fulker

 

Meghana Sharafudeen
+41 79 711 5554
msharafudeen@gavi.org
 

Meghana Sharafudeen

 

Evan O’Connell
+33 6 17 57 21 26
+41 22 909 6528
eoconnell@gavi.org

Evan O’Connell

Latest news releases

View all

Memorandum of understanding signed today will strengthen collaboration on vaccination efforts and related health services for migrants and forcibly displaced persons across the world

Geneva, 24 November 2020 – Gavi, the Vaccine Alliance, as co-lead of COVAX and administrator of the COVAX Facility, welcomes the release of interim efficacy data for the AstraZeneca/Oxford COVID-19 vaccine candidate.

The COVAX AMC Engagement Group, composed of Gavi COVAX AMC participants, donors, and other stakeholders, forms a key component of Facility governance.

The European Commission, France, Spain, The Republic of Korea and the Bill & Melinda Gates Foundation pledge US$ 360 million to Gavi’s COVID-19 Vaccines Advance Market Commitment (COVAX AMC)

The COVAX Shareholders Council, composed of all self-financing participants, forms a key component of Facility governance.

Media resources | assets

If you would you like to receive updates from the Gavi media team, or request access to our digital library of high-resolution images and B-roll, please email media@gavi.org.

Facts and figures

GAVI/2017/Guido Dingemans/Mozambique

Gavi factsheet: about the Vaccine Alliance

Gavi factsheet: about the Vaccine Alliance

Types of support

GAVI/2017/Juliette Bastin/Burkina Faso

Country hub

Country hub

Gavi leadership

 

Dr Ngozi Okonjo-Iweala
Board Chair

Dr Ngozi Okonjo-Iweala

Dr Seth Berkley
CEO

Seth Berkley, Gavi CEO. Credit: Gavi/Oscar Seijkens.

Anuradha Gupta
Deputy CEO

Anuradha Gupta
Last updated: 19 Oct 2020

Subscribe to our newsletter